Lixte Biotechnology Holdings, Inc. (LIXT)

LIXT Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-4.69	-5.09	-6.31	-6.73	-3.26	-2.44
Share-Based Compensation	0.6	0.77	1.55	2.6	1.25	0.75
Other Operating Activities	0.28	0.02	0.15	-0.01	-0.12	0.02
Operating Cash Flow	-3.81	-4.29	-4.61	-4.14	-2.13	-1.67
Change in Investments	1.29	-1.15	0.53	-0.25	2.47	-1.67
Investing Cash Flow	1.29	-1.15	0.53	-0.25	2.47	-1.67
Share Issuance / Repurchase	3.14	3.14	5.14	3.9	4.6	0
Financing Cash Flow	3.14	3.14	5.14	3.9	4.6	0
Net Cash Flow	-0.67	-1.15	0.53	-0.25	2.47	-1.67
Free Cash Flow	-3.81	-4.29	-4.61	-4.14	-2.13	-1.67
Free Cash Flow Per Share	-1.69	-2.24	-2.92	-3.08	-1.89	-1.50

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).